PMID- 22432552
OWN - NLM
STAT- MEDLINE
DCOM- 20120731
LR  - 20220408
IS  - 1751-7133 (Electronic)
IS  - 1527-5299 (Linking)
VI  - 18
IP  - 2
DP  - 2012 Mar-Apr
TI  - Adherence to evidence-based guidelines for heart failure in physicians and their 
      patients: lessons from the Heart Failure Adherence Retention Trial (HART).
PG  - 73-8
LID - 10.1111/j.1751-7133.2011.00263.x [doi]
AB  - The Heart Failure Adherence and Retention Trial (HART) provided an opportunity to 
      determine adherence to evidence-based guidelines (EBG) in patients with heart 
      failure (HF). Ten hospitals were the source of 692 patients with HF (EF < 40%). 
      Physicians of patients with HF were classified as adherent to EBG if the patient 
      chart audit showed they were on a beta-blocker, ACE-inhibitor (ACE-I), or 
      angiotensin receptor blocker (ARB). Patients were classified as adherent to EBG 
      if MEMS pill caps were used appropriately more than 80% of the time. Sixty-three 
      percent of physicians prescribed evidence-based medications that were adherent to 
      clinical practice guidelines. New York Heart Association (NYHA) III patients were 
      less likely to be adherent (P < 0.001), as were those with renal disease (P < 
      0.001) and asthmatics (P < 0.001). Nonadherent physicians were less likely to 
      treat patients with beta-blockers (39% vs 98%, P < 0.001) and ACE-I or ARBs (71% 
      vs 98% P < 0.001). Thirty-seven percent of patients prescribed evidence-based 
      therapy failed to use the MEMS pill cap bottles appropriately and were more 
      likely a minority or higher NYHA class. Adherence to evidence-based therapy is 
      less than optimal in HF patients based on a combination of both physician and 
      patient nonadherence.
CI  - (c) 2011 Wiley Periodicals, Inc.
FAU - Calvin, James E
AU  - Calvin JE
AD  - Section of Cardiology, Rush University Medical Center, Chicago, IL 60612-3833, 
      USA. james_calvin@rush.edu
FAU - Shanbhag, Sujata
AU  - Shanbhag S
FAU - Avery, Elizabeth
AU  - Avery E
FAU - Kane, John
AU  - Kane J
FAU - Richardson, Dejuran
AU  - Richardson D
FAU - Powell, Lynda
AU  - Powell L
LA  - eng
PT  - Journal Article
DEP - 20111103
PL  - United States
TA  - Congest Heart Fail
JT  - Congestive heart failure (Greenwich, Conn.)
JID - 9714174
RN  - 0 (Adrenergic beta-Antagonists)
RN  - 0 (Angiotensin Receptor Antagonists)
RN  - 0 (Angiotensin-Converting Enzyme Inhibitors)
SB  - IM
MH  - Adrenergic beta-Antagonists/therapeutic use
MH  - Angiotensin Receptor Antagonists/therapeutic use
MH  - Angiotensin-Converting Enzyme Inhibitors/therapeutic use
MH  - Chi-Square Distribution
MH  - Chicago
MH  - Confidence Intervals
MH  - Evidence-Based Medicine/*methods
MH  - Female
MH  - *Guideline Adherence
MH  - Heart Failure/*drug therapy
MH  - Humans
MH  - Logistic Models
MH  - Male
MH  - Medication Adherence/*statistics & numerical data
MH  - Middle Aged
MH  - Odds Ratio
MH  - Patient Compliance
MH  - Patient Education as Topic
MH  - *Practice Guidelines as Topic
MH  - Practice Patterns, Physicians'/*statistics & numerical data
EDAT- 2012/03/22 06:00
MHDA- 2012/08/01 06:00
CRDT- 2012/03/22 06:00
PHST- 2012/03/22 06:00 [entrez]
PHST- 2012/03/22 06:00 [pubmed]
PHST- 2012/08/01 06:00 [medline]
AID - 10.1111/j.1751-7133.2011.00263.x [doi]
PST - ppublish
SO  - Congest Heart Fail. 2012 Mar-Apr;18(2):73-8. doi: 
      10.1111/j.1751-7133.2011.00263.x. Epub 2011 Nov 3.